Spontaneous Tumor Lysis Syndrome in an Adenocarcinoma of Unknown Origin
- PMID: 33489580
- PMCID: PMC7813933
- DOI: 10.7759/cureus.12169
Spontaneous Tumor Lysis Syndrome in an Adenocarcinoma of Unknown Origin
Abstract
Spontaneous tumor lysis syndrome (STLS) is a rare oncologic emergency caused by massive cancer cell lysis or necrosis without a precipitating factor. Although tumor lysis syndrome (TLS) is most commonly associated with hematologic malignancies, a small number of cases in solid tumor malignancies have been reported. We present a case of spontaneous tumor lysis syndrome in a 77-year-old female with a widely metastatic, poorly differentiated adenocarcinoma of unknown origin. She presented in distributive shock, and laboratory testing at admission revealed acute renal failure, high anion gap metabolic acidosis, hyperuricemia, hyperkalemia, hyperphosphatemia, and hypocalcemia. Rasburicase and continuous renal replacement therapy were initiated, however, her condition deteriorated. Treatment was withdrawn and she died four days after admission.
Keywords: adenocarcinoma; tumor lysis.
Copyright © 2020, Kalter et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- Tumor lysis syndrome after induction of small-cell bronchogenic carcinoma. Vogelzang NJ, Nelimark RA, Nath KA. JAMA. 1983;249:513–514. - PubMed
-
- Tumour lysis syndrome: new therapeutic strategies and classification. Cairo MS, Bishop M. Br J Haematol. 2004;127:3–11. - PubMed
-
- Acute spontaneous tumor lysis presenting with hyperuricemic acute renal failure: clinical features and therapeutic approach. Hsu HH, Chan YL, Huang CC. https://pubmed.ncbi.nlm.nih.gov/15151259/ J Nephrol. 2004;17:50–56. - PubMed
-
- Acute spontaneous tumor lysis syndrome. Jasek AM, Day HJ. Am J Hematol. 1994;47:129–131. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous